Archive for the ‘biotech/medical’ category

Oct 16, 2019

Advantages of Neanderthal DNA in the Human Genome

Posted by in category: biotech/medical

Circa 2016

The retention of ancient hominin DNA in modern human genomes may have helped our ancestors adapt to life in diverse environments.

Oct 16, 2019

Changes in DNA

Posted by in categories: biotech/medical, evolution

Discover how changes in DNA can lead to evolution in species over time through mutations which are evidence for evolution.

Oct 16, 2019

How to Reverse Aging and Live Longer with David Sinclair PhD

Posted by in categories: biotech/medical, life extension

đź’Żđź’ŻSubscribe for videos on becoming superhuman:


Continue reading “How to Reverse Aging and Live Longer with David Sinclair PhD” »

Oct 16, 2019

Will We Ever Cure Breast Cancer?

Posted by in category: biotech/medical

Breast cancer is the second most common cancer diagnosed in women in the United States, right behind skin cancer. But how far have we come in understanding this disease?
» Subscribe to Seeker!
» Watch more SICK |

While breast cancer largely affects women, it can also occur in men. Fortunately, thanks to awareness, early detection, and research, survival rates have increased. But, there’s still a lot to learn, so Seeker sat down with Professor Donald McDonnell from the Duke School of Medicine to find out more.

Continue reading “Will We Ever Cure Breast Cancer?” »

Oct 16, 2019

A stem cell injection cured this woman’s blindness

Posted by in category: biotech/medical

Read more

Oct 16, 2019

In-Silico Clinical Trials — Virtual Bodies For Real Drugs — Dr. William Pruett — University of Mississippi Medical Center — ideaXme — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, DNA, futurism, genetics, health, life extension, neuroscience, science

Oct 16, 2019

This med student was given last rites before finding a treatment that saved his life. His method could help millions

Posted by in categories: biotech/medical, neuroscience

He lay in a hospital bed at the University of Arkansas, stricken with a rare disease. His blood platelet count was so low that even a slight bump to his body could trigger a lethal brain bleed. A doctor told him to write his living will on a piece of paper.

Fajgenbaum was rushed to a CT scan. Tears streamed down his face and fell on his hospital gown. He thought about the first patient who’d died under his care in medical school, and how her brain had bled in a similar way from a stroke.

He didn’t believe he’d live out the scan.

Oct 16, 2019

An Interview with Dr. Ronald Kohanski

Posted by in categories: biotech/medical, chemistry, life extension

It was a pleasure speaking to Dr. Ronald Kohanski at the 2019 Ending Age-Related Diseases conference. Dr. Kohanski joined the field of aging research in 2005 as a Program Officer for the Division of Aging Biology at the National Institute on Aging. He moved on to become its Deputy Director in 2007 and has held the position ever since. Within aging research, he has focused his efforts on the areas of stem cell and cardiovascular biology.

Besides his work at the NIA, Ronald Kohanski is a co-founder and co-leader of the trans-NIH Geroscience Interest Group (GSIG) with which he has organized several summits to discuss and disseminate the group’s focus. The GSIG directs its attention toward aging as the major risk factor for most chronic age-related diseases, and Dr. Kohanski actively encourages researchers to expand studies beyond laboratory animals. He underwrites the importance of addressing the basic biology of aging explicitly in human and non-laboratory animal populations. He believes that age should be considered a fundamental parameter in research that uses animal models of chronic disease.

Dr. Kohanski was trained in the field of biochemistry. He received his PhD from the University of Chicago in 1981, after which he conducted a postdoctoral fellowship with M. Daniel Lane at the Johns Hopkins University School of Medicine. He held a faculty position at the Mount Sinai School of Medicine for 17 years before returning to Johns Hopkins as a faculty member and researcher in the areas of enzymology and developmental biology of the insulin receptor.

Oct 16, 2019

The new Gods of esports are paralyzed from the neck down

Posted by in categories: biotech/medical, neuroscience

Players with quadriplegia are using neuroscience and video games to take on the world.

Oct 16, 2019

Qingsong Zhu at Ending Age-Related Diseases 2019

Posted by in categories: biotech/medical, life extension, robotics/AI

Dr. Qingsong Zhu, the COO of Insilico Medicine, discussed the use of deep learning in creating biomarkers for aging. Initially discussing existing clocks and the problems with animal translation, he went on to discuss what sorts of markers are ideal for age-related research and the details of training and testing a model that works with these markers, showing that a deep model compares favorably to other models.

He also used his model to show that smoking does, in fact, cause accelerated aging.

Page 1 of 84412345678Last